DR MALINDA ITCHINS

Dr Malinda Itchins BMedSci, MBBS(Hons1), PhD, FRACP, is a medical oncologist at Royal North Shore Hospital, GenesisCare, and North Shore Private.

In 2020 she graduated from her doctoral studies investigating drug resistance in ALK-rearranged non-small cell lung cancer both preclinically, and via a clinical trial. Malinda is the Lung Cancer Chair for the Clinical Oncology of Australia (COSA) Council, and Early Career Representative for the Thoracic Oncology Group of Australasia (TOGA) Scientific Committee. She is a Primary and Sub Investigator on a number of lung cancer clinical trials. Her research focus to date has been in patterns of care, the real-world experience and drug resistance in oncogene driven lung cancers and optimising the multidisciplinary care pathway and clinical predictors of survival in pancreatic cancer.

She is passionate about the evolution of precision medicine in cancer.  

Lung and Thoracic Cancers, Gastrointestinal Cancer